We found no evidence of point mutations in NF1, SUZ12 or in any of the genes encoding other PRC2 (EED, EZH1 and EZH2) components in either the 2XSB cell line or the parent tumor (Fig. 7a). This evidence concerns the gene SUZ12 and neoplasm.